Latest GPC Biotech AG Stories

2008-10-27 06:00:23

GPC Biotech AG (Frankfurt Stock Exchange: GPC, NASDAQ: GPCB) today reported that pre-clinical data on RGB-286638, the Company's multi-targeted protein kinase inhibitor, were presented at the 20th EORTC-NCI-AACR Symposium: Molecular Targets and Cancer Therapeutics in Geneva, Switzerland in a poster entitled, "RGB-286638 is a novel multi-targeted protein kinase inhibitor with activity in chronic myelogenous leukemia (CML) models," (Abstract #578).

2008-06-25 00:02:49

Study seeks to determine if presence of certain gene impacts patient outcome GPC Biotech AG Investor Relations & Corporate Communications +49 (0)89 8565-2693 ir@gpc-biotech.com or In the U.S.: Laurie Doyle, Director, Investor Relations & Corporate Communications, +1 609-524-5884 usinvestors@gpc-biotech.com or Additional media contacts for Europe: MC Services AG Raimund Gabriel, +49 (0) 89 210 2280 raimund.gabriel@mc-services.eu or Stefan Riedel, +49 (0) 89 210 2280...

Word of the Day
  • The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.
The word 'logocentrism' is a blend of logo- +‎ centrism.